Chemical Structure (Levetiracetam 01)
Levetiracetam Solution
Product Images NDC 63739-158
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Levetiracetam (NDC 63739-158). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Mckesson Corporation Dba Sky Packaging, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure 1 (Levetiracetam 02)
This is not-available as the text seems to be a list of numeric percentages and some incomplete words without clear context or structure.*
Figure 2 (Levetiracetam 03)
Figure 3 (Levetiracetam 04)
This appears to be a chart or table that shows the percentage of patients receiving a certain treatment. It is unclear what the treatment is or what the percentages correspond to, as there is no context or labels provided. The only clear information is that a certain group of patients received 3000 milligrams per day of a medication called Levetiracstam, but it is unknown what condition this medication is being used to treat or what the outcome of the treatment was. Therefore, the usefulness of this information is limited without additional context.*
Figure 4 (Levetiracetam 05)
This data shows the percentage of patients who were administered Lovetiracetam in a sample of 101 individuals. The percentages for each category are: 5%, 0%, 35%, 0%, 25%, 20%, 15%, 10%, 5%, 0%, 19.6%, and 44.6%.*
Figure 5 (Levetiracetam 06)
This seems to be a chart or table showing the percentage effectiveness of two drugs, Levtracetan and Placebo, for a particular purpose. Levtracetan appears to be 43.1% effective compared to Placebo, which is only 19.6% effective. The information suggests that Levtracetan is statistically significant in its effectiveness compared to Placebo. However, without additional context, the purpose of the drugs or the condition being treated, it is difficult to provide more details.*
Figure 6 (Levetiracetam 07)
This is a table displaying the percentage of patients who took Levetiracetam, with the sample size being 79. The table shows the percentage of patients from 0% to 100% in increments of 10%, with a highlighted value of 45.2% at an unknown interval. There is also another highlighted value of 72.2%, but it is uncertain what this number represents.*
Principal Display Panel (5 mL Cup Label)
This is a description of a medication called Levetiracetam, which comes in the form of a 500mg/5mL oral solution. The product is intended only for institutional use and requires a prescription. The product information includes its National Drug Code (NDC) number 6373915870 and the name and location of the distributor, which is SKY Packaging in Memphis, TN. However, the text is cut off at the end, and has some errors.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
